InMed AI

InMed AI, officially known as InMed Prognostics, is a health technology company specializing in AI-powered medical image analysis to support the early detection and management of neurodegenerative diseases. The company's flagship platform, NeuroShield, utilizes deep learning algorithms to provide automated, high-precision volumetric analysis of brain MRI scans. By quantifying changes in brain structures, the technology assists clinicians in diagnosing conditions such as Alzheimer's, Parkinson's, and Multiple Sclerosis. InMed AI aims to bridge the gap between complex imaging data and actionable clinical insights, improving patient outcomes through objective prognostic tools. The company primarily serves radiologists and neurologists across hospitals and diagnostic centers.